New heart attack treatment aims to 'Passivate' dangerous plaque
NCT ID NCT06791031
Summary
This study is testing if adding a PCSK9 inhibitor drug to standard cholesterol treatment right after a heart attack helps make artery plaque more stable and less likely to cause another event. It will involve 212 patients who recently had a heart attack. Doctors will use advanced imaging to measure changes in the plaque inside patients' arteries over 6 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.